These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27388431)

  • 1. Serum and Plasma Levels of Vascular Endothelial Growth Factors in Relation to Quality of Glucose Control, Biomarkers of Inflammation, and Diabetic Nephropathy.
    Hanefeld M; Appelt D; Engelmann K; Sandner D; Bornstein SR; Ganz X; Henkel E; Haase R; Birkenfeld AL
    Horm Metab Res; 2016 Aug; 48(8):529-34. PubMed ID: 27388431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus.
    Jiang Y; Li J; Zhang J; Chen S
    Front Endocrinol (Lausanne); 2023; 14():1274025. PubMed ID: 38075072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Angiopoietin-2 and vascular endothelial growth factor as markers of diabetic nephropathy onset in Egyptians diabetic patients with non-albuminuric state.
    Aly MH; Arafat MA; Hussein OA; Elsaid HH; Abdel-Hammed AR
    Diabetes Metab Syndr; 2019; 13(2):1623-1627. PubMed ID: 31336531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of C-reactive protein on the occurrence and assessing of albuminuria severity in diabetics.
    Pojskić L; Hasić S; Tahto E; Arnautović-Torlak V; Pojskić B
    Med Glas (Zenica); 2018 Feb; 15(1):10-15. PubMed ID: 29214987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes: A cohort study.
    Zhang Q; Fang W; Ma L; Wang ZD; Yang YM; Lu YQ
    Medicine (Baltimore); 2018 Apr; 97(15):e0415. PubMed ID: 29642210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
    Bonnefond A; Saulnier PJ; Stathopoulou MG; Grarup N; Ndiaye NC; Roussel R; Nezhad MA; Dechaume A; Lantieri O; Hercberg S; Lauritzen T; Balkau B; El-Sayed Moustafa JS; Hansen T; Pedersen O; Froguel P; Charpentier G; Marre M; Hadjadj S; Visvikis-Siest S
    PLoS One; 2013; 8(2):e55921. PubMed ID: 23405237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy.
    Shimada K; Baba T; Neugebauer S; Onozaki A; Yamada D; Midorikawa S; Sato W; Watanabe T
    J Diabetes Complications; 2002; 16(6):386-90. PubMed ID: 12477622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.
    Schlingemann RO; Van Noorden CJ; Diekman MJ; Tiller A; Meijers JC; Koolwijk P; Wiersinga WM
    Diabetes Care; 2013 Jun; 36(6):1629-34. PubMed ID: 23321217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell-selective adhesion molecule in diabetic nephropathy.
    Kacso IM; Kacso G
    Eur J Clin Invest; 2012 Nov; 42(11):1227-34. PubMed ID: 22957687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy.
    Zehetner C; Kirchmair R; Kralinger M; Kieselbach G
    Acta Ophthalmol; 2013 Sep; 91(6):e470-3. PubMed ID: 23452413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
    Shao Y; Lv C; Yuan Q; Wang Q
    J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes.
    Hanefeld M; Engelmann K; Appelt D; Sandner D; Weigmann I; Ganz X; Pistrosch F; Köhler C; Gasparic A; Birkenfeld AL
    PLoS One; 2017; 12(10):e0184234. PubMed ID: 28991900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
    Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC
    Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy.
    Shelbaya S; Abu Shady MM; Nasr MS; Bekhet MM; Mageed YA; Abbas M
    Curr Diabetes Rev; 2018; 14(5):481-486. PubMed ID: 28875825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered oxidant and antioxidant levels are associated with vascular stiffness and diabetic kidney disease in type 1 diabetes after exposure to acute and chronic hyperglycemia.
    Adeshara K; Di Marco E; Bordino M; Gordin D; Bernardi L; Cooper ME; Groop PH;
    Cardiovasc Diabetol; 2024 Sep; 23(1):350. PubMed ID: 39342285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of high sensitivity C-reactive protein and glycated hemoglobin levels in diabetic nephropathy.
    Roopakala MS; Pawan HR; Krishnamurthy U; Wilma Delphine Silvia CR; Eshwarappa M; Prasanna Kumar KM
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):286-9. PubMed ID: 22382220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients.
    Kakizawa H; Itoh M; Itoh Y; Imamura S; Ishiwata Y; Matsumoto T; Yamamoto K; Kato T; Ono Y; Nagata M; Hayakawa N; Suzuki A; Goto Y; Oda N
    Metabolism; 2004 May; 53(5):550-5. PubMed ID: 15131756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy.
    Lu J; Randell E; Han Y; Adeli K; Krahn J; Meng QH
    Clin Biochem; 2011 Mar; 44(4):307-11. PubMed ID: 21126514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
    Shahid SM; Nawab SN; Shaikh R; Mahboob T
    Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
    Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
    J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.